Boyen Therapeutics, Inc.
Records under this name other than the patents Boyen Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 2 of 2 · Back to Boyen Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,540,410 | Gemcitabine prodrugs and uses thereof Lapsed on the fee record Ended Jan 10, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 10, 2021 | USPTO record |
| US 8,956,613 | Gemcitabine prodrugs and uses thereof Lapsed on the fee record Ended Feb 17, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 17, 2019 | USPTO record |